# ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts

> **NCT02519608** · PHASE2 · COMPLETED · sponsor: **University Hospital of Ferrara** · enrollment: 44 (actual)

## Conditions studied

- Coronary Artery Disease
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Aspirin 100 mg
- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02519608
- **Lead sponsor:** University Hospital of Ferrara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-06
- **Final completion:** 2017-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2018-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02519608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02519608, "ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02519608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*